EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update

We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test wi...

Full description

Bibliographic Details
Main Authors: Alessandro Fulgenzi, Daniele Vietti, Maria Elena Ferrero
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/8/8/269
_version_ 1827711768544149504
author Alessandro Fulgenzi
Daniele Vietti
Maria Elena Ferrero
author_facet Alessandro Fulgenzi
Daniele Vietti
Maria Elena Ferrero
author_sort Alessandro Fulgenzi
collection DOAJ
description We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNA<sub>2</sub>EDTA or EDTA) to identify the presence of 20 toxic metals in urine samples using inductively coupled plasma mass spectrometry. Our results show the constant presence of toxic metals, such as lead, cadmium, cesium, and aluminum, in all examined subjects but the absence of beryllium and tellurium. Gadolinium was detected in patients undergoing diagnostic magnetic resonance imaging. The presence of toxic metals was always significantly more elevated in ND patients than in healthy controls. Treatment with EDTA chelation therapy removes toxic-metal burdens and improves patient symptoms.
first_indexed 2024-03-10T18:00:13Z
format Article
id doaj.art-9f71f56c0adf43b6abfa2b1b5b340e3c
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T18:00:13Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-9f71f56c0adf43b6abfa2b1b5b340e3c2023-11-20T08:54:51ZengMDPI AGBiomedicines2227-90592020-08-018826910.3390/biomedicines8080269EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An UpdateAlessandro Fulgenzi0Daniele Vietti1Maria Elena Ferrero2Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via Mangiagalli, 31, 20133 Milan, ItalyDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Via Mangiagalli, 31, 20133 Milan, ItalyDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Via Mangiagalli, 31, 20133 Milan, ItalyWe have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNA<sub>2</sub>EDTA or EDTA) to identify the presence of 20 toxic metals in urine samples using inductively coupled plasma mass spectrometry. Our results show the constant presence of toxic metals, such as lead, cadmium, cesium, and aluminum, in all examined subjects but the absence of beryllium and tellurium. Gadolinium was detected in patients undergoing diagnostic magnetic resonance imaging. The presence of toxic metals was always significantly more elevated in ND patients than in healthy controls. Treatment with EDTA chelation therapy removes toxic-metal burdens and improves patient symptoms.https://www.mdpi.com/2227-9059/8/8/269EDTA chelation therapyneurodegenerative diseasesmetal detoxification
spellingShingle Alessandro Fulgenzi
Daniele Vietti
Maria Elena Ferrero
EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
Biomedicines
EDTA chelation therapy
neurodegenerative diseases
metal detoxification
title EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_full EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_fullStr EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_full_unstemmed EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_short EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_sort edta chelation therapy in the treatment of neurodegenerative diseases an update
topic EDTA chelation therapy
neurodegenerative diseases
metal detoxification
url https://www.mdpi.com/2227-9059/8/8/269
work_keys_str_mv AT alessandrofulgenzi edtachelationtherapyinthetreatmentofneurodegenerativediseasesanupdate
AT danielevietti edtachelationtherapyinthetreatmentofneurodegenerativediseasesanupdate
AT mariaelenaferrero edtachelationtherapyinthetreatmentofneurodegenerativediseasesanupdate